SCHEMBL7964218

SCHEMBL7964218

NC(CO)Cc1cscn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 3/20 0.39
DPP8 Q6V1X1 2/20 0.39
DPP9 Q86TI2 2/20 0.39
GPR142 Q7Z601 4/20 0.36
SLC6A3 Q01959 4/20 0.35
SYK P43405 1/20 0.35
MEN1 O00255 1/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
PRKCI P41743 1/20 0.34
PKM P14618 1/20 0.33
OPRD1 P41143 1/20 0.33
CAPN1 P07384 1/20 0.32
MAPK1 P28482 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
ALDH1A1 P00352 1/20 0.31
TSHR P16473 1/20 0.31
KDM4C Q9H3R0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20279044 1.00 DPP4 (0.39) DPP4DPP8DPP9GPR142SLC6A3
SCHEMBL7964213 1.00 DPP4 (0.39) DPP4DPP8DPP9GPR142SLC6A3
SCHEMBL19214802 0.81 DPP4 (0.36) DPP4DPP8DPP9GPR142SLC6A3
SCHEMBL13624897 0.81 DPP4 (0.36) DPP4DPP8DPP9GPR142SLC6A3
SCHEMBL16889011 0.80
SCHEMBL8739022 0.78 DPP4 (0.36) DPP4DPP8DPP9SLC6A3SYK
SCHEMBL4551356 0.78 DPP4 (0.36) DPP4DPP8DPP9SLC6A3SYK
SCHEMBL19143537 0.77 DPP4 (0.39) DPP4DPP8DPP9GPR142SLC6A3
SCHEMBL2627123 0.77 DPP4 (0.34) DPP4DPP8DPP9SLC6A3SYK
Serine SCHEMBL3839203 0.76 DPP4 (0.45) DPP4DPP8DPP9GPR142SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6274715-B1 SEMISYNTHETIC MACROLIDES, USEFUL IN BACTERIAL INFECTIONS TREATMENT AND PREVENTION, HAS LESS POTENTIAL FOR DEVELOPING RESISTANCE, IMPROVED OR MODIFIED PROFILES OF DESIRED GRAM-NEGATIVE ACTIVITY ABBOTT LABORATORIES 2001-08-14 US disclosed
CN-1244202-A Tricyclic erythromycin derivatives ABBOTT LAB (US) 2000-02-09 CN disclosed